DY

David Yang

Investment Team at Lux Capital

San Francisco Bay Area

Overview

Work Experience

  • Investment Team

    2024 - Current

  • Co-founder, Head of Ops & Strategy

    2022 - 2024

  • Investment Team

    2020 - 2024

    Early-stage life sciences investments & incubations. Select portfolio: Photys Tx, Dren Bio, Latus Bio, Atomic AI (Board Observer), Unlearn AI (Board Observer), Tilda Research (Board Observer), Flywheel (Board Observer), Latent Labs (Board Observer), Portal Bio, Orchestra Bio Started the Bio-IT Fellowship to partner with entrepreneurial scientists: https://www.8vc.com/bio-it-fellowship

  • Research Associate

    2017 - 2020

    RNA targeting CRISPR systems for viral diagnostics and surveillance at the Pardis Sabeti lab * HC Metsky et al. Nature Biotechnology (2022) * DS Griesemer et al. Cell (2021) * CM Ackerman and C Myhrvold et al. Nature (2020) * DK Yang et al. Machine Learning in Computational Biology (2019) * HC Metsky and KJ Siddle et al. Nature Biotechnology (2019) https://scholar.google.com/citations?user=09tlyHEAAAAJ&hl

Relevant Websites